|
Market Closed -
Nasdaq
00:00:00 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 146.74 USD | +0.42% |
|
+5.63% | +19.55% |
| 08-25 | Lakefront Gets FDA Orphan Drug Label for Gamgertamig | MT |
| 08-25 | Lakefront Biotherapeutics Autoimmune Disorder Pemphigus Treatment Gets FDA Orphan Drug Designation | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.42% | +5.63% | +13.48% | +9.21% | +19.55% | +27.86% | +92.24% | +103.10% | +82.29% | 181B | |
| -0.67% | +5.39% | +4.26% | +17.08% | +16.03% | +75.21% | +127.54% | +374.53% | +1,489.66% | 1,119B | |
| +1.04% | +4.07% | +3.66% | +16.51% | +31.94% | +52.29% | +65.39% | +55.68% | +130.01% | 651B | |
| -0.17% | +5.67% | +1.99% | +22.63% | +15.77% | +25.60% | +80.40% | +121.02% | +306.58% | 468B | |
| -1.38% | +4.02% | +4.31% | +10.73% | +12.86% | +41.64% | +42.38% | +1.09% | +52.11% | 374B | |
| -0.52% | +2.72% | -0.11% | +6.11% | +15.66% | +24.32% | +41.06% | +49.98% | +61.58% | 302B | |
| -1.06% | +4.76% | -4.42% | -12.98% | -12.18% | +1.19% | +12.65% | +41.97% | +138.39% | 259B | |
| +1.03% | +5.83% | +18.03% | +30.81% | +35.60% | +51.11% | +72.96% | +97.81% | +159.80% | 238B | |
| -0.53% | +2.34% | -6.66% | +3.55% | -7.99% | -17.77% | -53.66% | -9.17% | +90.36% | 208B | |
| -0.36% | +4.09% | +13.98% | +7.99% | +12.33% | +8.08% | -22.65% | -42.19% | -19.67% | 160B | |
| -0.08% | +6.21% | +14.71% | +26.02% | +20.78% | +38.59% | +57.91% | +174.17% | +466.22% | 139B | |
| +0.40% | +4.10% | +8.36% | +13.15% | +24.73% | +40.40% | +9.79% | -1.81% | +14.83% | 137B | |
| -0.84% | +2.11% | +2.96% | +1.82% | -5.37% | -10.37% | -20.23% | -11.63% | +13.30% | 110B | |
| -1.46% | +2.11% | -1.51% | -1.28% | +3.62% | +27.78% | +37.83% | +1.93% | -8.81% | 105B | |
| -0.80% | +1.31% | +1.30% | -14.54% | -15.84% | +11.71% | +60.88% | +61.55% | +517.54% | 72.56B | |
| -0.29% | +1.35% | +0.17% | +13.22% | +19.52% | +28.08% | +29.89% | +56.27% | +27.26% | 57.89B | |
| +0.92% | +1.21% | +5.25% | +25.89% | +30.99% | +69.78% | -2.83% | +0.89% | -49.88% | 55.1B | |
| -2.05% | -11.56% | -12.52% | -7.35% | -21.50% | -28.04% | +15.63% | -0.93% | +185.96% | 46.76B | |
| +1.85% | +5.60% | +1.73% | +7.56% | -1.33% | +1.45% | +13.33% | - | - | 43.6B | |
| -1.10% | +1.29% | +19.86% | +8.39% | +18.33% | +100.05% | +281.90% | +289.97% | -28.47% | 43.51B | |
| Average | -0.28% | +3.20% | +4.44% | +9.23% | +10.67% | +28.45% | +47.12% | +71.80% | +191.00% | 238.51B | |
| Weighted average by Cap. | -0.26% | +4.52% | +4.23% | +12.78% | +15.16% | +39.89% | +63.82% | +130.08% | +454.60% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
